George Clinical team will join the 11th Asia Pharma R&D Leaders Summit 2022 on August 26 – 27. Zhenfei Yin, George Clinical’s Head, Project Operations, China, will be there to share the strategies for early phase in MRCT.
The 11th Asia Pharma R&D Leaders (APRL) is a high-end strategic summit in Asia focusing on drug discovery and development. This annual R&D event has been accompanying Chinese and global drug development leaders for ten years. The 11th APRL 2022 will once again bring together top experts in new drug R&D from global multinational pharmaceutical companies, domestic and international biotechnology companies, scientific research institutes and other institutions. APRL 2022 will focus on clinical value-oriented and patient-centered drug development and innovation, work together to improve the efficiency of clinical development, accelerate the speed of new drug development to market, actively explore differentiated R&D strategies, promote the internationalization of innovation drug development, and connect global drug R&D Leaders, work together to overcome human medical problems and unmet clinical needs!
As Country Head and Regional Head of Project Operations, China, Zhenfei is responsible for leading the operations teams across China. Zhenfei Yin brings with him more than 14 years of substantial industry experience leading Clinical Operations, Project Management, and Business Development teams across the CRO and Pharmaceutical sectors, including experience in Electronic Data Capture trials. Zhenfei, fluent in English and Chinese, obtained his degree in Clinical Medicine from Shanxi Medical University and also holds a Master’s Degree in Surgery from Peking University.
Meet with George Clinical! Contact us to schedule a time now.